One-year results from the PINNACLE FLX trial show Boston Scientific Corp.’s WATCHMAN FLX system can safely and effectively close the left-atrial appendage closure device in patients with non-valvular atrial fibrillation.
Shephal Doshi of the Pacific Heart Institute in Santa Monica, CA, presented the 12-month follow-up data from the trial during the Heart Rhythm Society’s online scientific sessions on 8 May